Clinical Trial Update: SGM-101 in Colorectal Brain Metastases. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SGM-101 for colorectal cancer with brain metastases is currently recruiting at Leiden University Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• SGM-101

Snippet

Sponsor: Leiden University Medical Center | Conditions: Rectal Neoplasms, Rectum Cancer | Phase 2 | Status: RECRUITING